OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

Ciara Mageean, Olympic Runner and European Champion, Dies at 34 After Stage 4 Bowel Cancer

Financial Discrimination Against Cancer Survivors: Why the Right to Be Forgotten Is a Global Imperative

GDFATHER-NEO: Neoadjuvant Nivolumab + Visugromab in MIBC

Oncology News, Insights, Stories by OncoDaily

LungÕ 2026 – Virtual Global Congress on Lung Oncology
Projects

LungÕ 2026 – Virtual Global Congress on Lung Oncology

FDA
Not To Miss

FDA Issues New Guidance on Cell and Gene Therapy Potency

L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care
Not To Miss

L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care

Christian Ntizimira: Why We Should Stop Saying 'End-of-Life Care' and Start Saying 'Life Until the End'

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

Nicholas Hornstein: Could Botensilimab and Balstilimab Change the Future of MSS Colorectal Cancer?

Early Relapsed Myeloma: No Efficacy Hierarchy Established Between CAR T Cells and Bispecific Antibodies

Savolitinib and Osimertinib Combination for NSCLC Moves Closer to Approval in Europe and Japan

NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer

Layth Mula-Hussain: An Institutional Step Towards the Future of Radiation Therapy in the Arab World

Voices
Jennifer Guerriero

Jennifer Guerriero: A Personal Breast Cancer Story and the Power of Screening

Andrew Bankouski: My First ESMO Congress Experience and the Value of Networking and Mentorship

Olubukola Ayodele: Highlights From Day 1 of London Global Cancer Week 2026

ESO Celebrates the First Event of Its Educational Series Towards Its 50th Anniversary

Total Marrow Lymphoid Radiation (TMLI) Improve Transplant Outcome for Acute Leukemia - Resonance

Michelle Mitchell: How Are Cancer Research UK Colleagues Making a Difference Together?

Eduard-Alexandru Bonci to Share Surgical Perspectives on NSABP B-51/RTOG 1304 at ESSO45 Congress

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

SITC 2026

Society for Immunotherapy of Cancer

04 Nov
SITC

The ACCC Oncology Reimbursement Meeting – Reno

Association of Cancer Care Centers (ACCC)

04 Nov
ACCC Oncology

EORTC Genito-Urinary Cancer Group Autumn Meeting 2026

04 Nov
Genito-Urinary Cancer

Cancer Research UK Lung Cancer Centre of Excellence – Conference 2026

Cancer Research UK

04 Nov
Cancer Research UK

International Symposium of Critical Care in Cancer Patients

MD Anderson Cancer Center

04 Nov
International Symposium of Critical Care

European Course in Paediatric Radiology (ECPR) 2026 – Module 2

European Society of Paediatric Radiology (ESPR)

04 Nov
Paediatric Radiology

SLACOM – New and Innovative Strategies in Global Cancer Prevention: Ultrascreening and Risk Reduction Strategies

Latin American and Caribbean Society of Medical Oncology (SLACOM)

04 Nov
SLACOM

IHCRI-Rwanda – Strengthening Global Cancer Research, Collaboration, and Capacity Building

Internal Health Cancer and Research Initiative Rwanda (IHCRI-Rwanda)

04 Nov
IHCRI

Best of IMS Asia Pacific Webinar Series

International Myeloma Society (IMS)

04 Nov
IMS Asia Pacific Webinar

24th Annual School of Breast Oncology 2026

Physicians’ Education Resource

05 Nov
Breast Oncology

SIOG 2026 Annual Conference

International Society of Geriatric Oncology (SIOG)

05 Nov
SIOG 2026 Annual Conference

The CAMO 2026 Annual Scientific Meeting

Canadian Association of Medical Oncologists (CAMO)

05 Nov
CAMO 2026

Immune-oncology
Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment

KEYFORM-007: Dual PD-1/LAG-3 Blockade in MSS Colorectal Cancer

Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy

Can the Tumor’s Own B Cells Reveal the Next Immunotherapy Target?

ESMO 2026: The Key Pembrolizumab Trials to Know

ESMO 2026: What’s New in Melanoma Immunotherapy?

KEYNOTE-C93 Trial: Pembrolizumab Versus Chemotherapy in dMMR Endometrial Cancer

Gastrointestinal-Oncology
NICHE-2

NICHE-2: Long-Term Survival Outcomes With Neoadjuvant Immunotherapy in dMMR Colon Cancer

UNICORN Challenges Immunotherapy Resistance in MSS Colon Cancer

10 Must-Read Posts in GI Oncology This Week

Top Gastroesophageal Cancer Updates From ESMO 2026

FOLFOX Chemotherapy: What It Is, Drugs, Uses, Cycles, and Side Effects

Phase III PRABITAS Trial: 14-Day vs 28-Day Lonsurf Plus Bevacizumab for Refractory mCRC

Key Updates in GI Oncology From ESMO 2026

Breast-Oncology
Neoadjuvant Carboplatin

Neoadjuvant Carboplatin Improves Event-Free Survival in Early TNBC: Pooled Analysis of Three Randomized Trials Strengthens the Evidence

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing Results

Trastuzumab Deruxtecan Secures EU Approval for Residual HER2-Positive Early Breast Cancer Following DESTINY-Breast05 Survival-Free Disease Benefit

A New Chance to Prevent Recurrence: EU Approves Trastuzumab Deruxtecan for HER2-Positive Early Breast Cancer

Biomarker Landscape of ADCs and Bispecific Antibodies in Breast Cancer: The 2026 Clinical Trial Breakthroughs and Future of Precision Treatment

Inflammatory Breast Cancer in 2026: Evolving Diagnostic Criteria, Modern Trimodality Treatment, and the Challenge of Improving Survival

Triple-Negative Breast Cancer in Algeria in 2026: What Has Changed?

Lung-Oncology
LungÕ 2026

LungÕ 2026: Integrating Care and Advancing Treatment for Locally Advanced Lung Cancer

Tarlatamab-Associated Neurotoxicity in SCLC: New Study Identifies TIAN in Patients With Brain Metastases

Neoadjuvant Immunotherapy Linked to Improved Five-Year Survival in Resected NSCLC: Real-World Study Supports Long-Term Benefit Without Increased Surgical Morbidity

Biomarker Landscape of ADCs and Bispecific Antibodies in Lung Cancer: The 2026 Clinical Trial Evidence and Future of Precision Treatment

ASCO 2026.3.4 Living Guideline: Lorlatinib Takes Priority in First-Line ALK-Positive NSCLC After Landmark Seven-Year CROWN Results

KEYNOTE-867 Phase III: Pembrolizumab Plus SBRT Fails to Improve Event-Free Survival and Increases Severe Toxicity in Early-Stage NSCLC

What Changes in Lung Oncology After ESMO 2026? Survival Breakthroughs, ADC Competition, and a New Era of Precision Treatment

OncoDaily TV
Dr Gevorg Tamamyan

Mongolia’s Former Minister of Health Dr Chinburen Jigjidsuren Will Join the International Advisory Board of Dr Gevorg Tamamyan’s WHO DG Campaign

Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Not To Miss
Dren Bio

Dren Bio Raises $350M to Advance Dibotatug Toward Commercialization

London Global Cancer Week 2026: What's Coming on November 4

Natera’s Signatera MRD Test Gains Broader Medicare Coverage for Liver Cancer Surveillance

Young Investigators and New Ideas Take the Spotlight at Northeast GI Oncology Congress 2026

Savolitinib and Osimertinib Combination for NSCLC Moves Closer to Approval in Europe and Japan

FDA Issues New Guidance on Cell and Gene Therapy Potency

Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder

OncoGrants
Canadian Association of Medical Oncologists

Canadian Association of Medical Oncologists (CAMO) 2027 Fellowship Program

KI–Mayo Clinic

Cancer Research KI–Mayo Clinic CCC Synergy Grants 2027–2031

Long-term International Fellowship

Conquer Cancer Long-term International Fellowship 2027

Award in Ovarian Cancer

Conquer Cancer Career Development Award in Ovarian Cancer 2027

Special Fellowship Funding

Yorkshire Cancer Research 2027 Special Fellowship Funding Round

Liver Cancer

Cancer Australia–NHMRC Liver Cancer Prevention and Early Detection Grants 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Hagar El-Ghazawy

Hagar El-Ghazawy

Oncologists Location Cairo, Egypt
Dragana Stanić Tišma

Dragana Stanić Tišma

Oncologists Location Belgrade, Serbia
Sarah Nyagabona

Sarah Nyagabona

Oncologists Location Dar es Salaam, Tanzania
Trinanjan Basu

Trinanjan Basu

Oncologists Location Mumbai, India
Gregory Kalemkerian

Gregory Kalemkerian

Oncologists Location Ann Arbor, USA
Monica Malik

Monica Malik

Oncologists Location Hyderabad, India
Vlad Alexandru Gâta

Vlad Alexandru Gâta

Oncologists Location Cluj-Napoca, Romania
Chi-kong Li

Li Chi-kong

Oncologists Location Hong Kong, China

Drugs Atlas
Pertuzumab (Perjeta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Pertuzumab (Perjeta) Nov 3, 2026 9:23 am
Trastuzumab (Herceptin): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Trastuzumab (Herceptin) Nov 2, 2026 5:11 pm
Ofatumumab (Arzerra, Kesimpta): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Ofatumumab (Arzerra, Kesimpta) Nov 1, 2026 1:25 am
Obinutuzumab (Gazyva): Mechanism of Action, Dosing, Clinical Uses, Trials, and Side Effects Obinutuzumab (Gazyva; Gazyvaro) Nov 1, 2026 1:23 am
Sotorasib (Lumakras; AMG 510): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in KRAS G12C-Mutated Lung and Colorectal Cancer Sotorasib (Lumakras; AMG 510) Oct 31, 2026 6:38 am
Rituximab (Rituxan; MabThera): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in B-Cell Malignancies and Autoimmune Diseases Rituximab (Rituxan; MabThera) Oct 31, 2026 6:37 am
Adagrasib (Krazati; MRTX849): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in KRAS G12C-Mutated Cancers Adagrasib (Krazati; MRTX849) Oct 30, 2026 12:57 am
Infigratinib (Truseltiq; BGJ398): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR2-Rearranged Cholangiocarcinoma Infigratinib (Truseltiq; BGJ398) Oct 30, 2026 12:56 am
Futibatinib (Lytgobi): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR2-Rearranged Intrahepatic Cholangiocarcinoma Futibatinib (Lytgobi) Oct 28, 2026 1:27 pm
Pemigatinib (Pemazyre): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in FGFR-Driven Cancers and Myeloid/Lymphoid Neoplasms Pemigatinib (Pemazyre) Oct 28, 2026 1:02 am

OncoDaily Magazine

New Paper Alert
Narjust Florez

Narjust Florez: TKIs in Pregnancy for Lung Cancer

Stephen Liu

Stephen Liu: TKI-Based Induction Therapy Enables Surgery in Initially Unresectable EGFR-Mutant NSCLC

Partha Basu

Partha Basu's New Paper on the Potential of Handheld Ultrasound by Trained Nonradiologists

Gilberto Lopes

Gilberto Lopes Highlights Critical Links Between Lung Cancer Stigma, Depression and Anxiety

Ajay Aggarwal

Ajay Aggarwal: National Quality Improvement Can Transform Prostate Cancer Radiation Therapy Outcomes

Angela Mastronuzzi

Angela Mastronuzzi: M.A.P.-RT Validated in 268 Pediatric Patients to Improve Radiotherapy Planning and Support

OncoDaily Medical Journal

GU Oncology

10.69690/ODMJ-001-1026-8269

Psychosocial burden and lifestyle impact in patients with renal cell carcinoma: a patient-reported outcomes analysis
Original Research

Pediatric Oncology

10.69690/ODMJ-001-1026-8309

Limited Prognostic Value of Baseline Curie Score in Children with High-Risk Neuroblastoma Treated with Contemporary Multi-modal Therapy: A Single-Center Retrospective Cohort Study
Original Research

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews